MC
TMO icon

Middleton & Co’s Thermo Fisher Scientific TMO Stock Holding History

Middleton & Co’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52M Hold
5,137
– – 0.29% 66
2025
Q4 		$2.98M Sell
5,137
-30
-0.6% -$17K 0.32% 61
2025
Q3 		$2.51M Sell
5,167
-15
-0.3% -$6.98K 0.27% 67
2025
Q2 		$2.1M Sell
5,182
-69
-1% -$28.9K 0.24% 74
2025
Q1 		$2.61M Sell
5,251
-6
-0.1% -$3.25K 0.31% 68
2024
Q4 		$2.73M Buy
5,257
+30
+0.6% +$16.5K 0.3% 66
2024
Q3 		$3.23M Sell
5,227
-5
-0.1% -$2.96K 0.36% 60
2024
Q2 		$2.89M Hold
5,232
– – 0.34% 63
2024
Q1 		$3.04M Buy
5,232
+10
+0.2% +$5.61K 0.35% 62
2023
Q4 		$2.77M Sell
5,222
-50
-0.9% -$24.2K 0.35% 63
2023
Q3 		$2.67M Sell
5,272
-50
-0.9% -$26.6K 0.37% 62
2023
Q2 		$2.78M Sell
5,322
-113
-2% -$61K 0.37% 63
2023
Q1 		$3.13M Sell
5,435
-89
-2% -$50.2K 0.45% 59
2022
Q4 		$3.04M Sell
5,524
-578
-9% -$306K 0.45% 61
2022
Q3 		$3.1M Sell
6,102
-5,571
-48% -$3.12M 0.47% 60
2022
Q2 		$6.34M Sell
11,673
-385
-3% -$212K 0.81% 45
2022
Q1 		$7.12M Buy
12,058
+400
+3% +$230K 0.76% 49
2021
Q4 		$7.78M Sell
11,658
-35
-0.3% -$21.9K 0.76% 48
2021
Q3 		$6.68M Sell
11,693
-144
-1% -$79K 0.72% 50
2021
Q2 		$5.97M Buy
11,837
+499
+4% +$235K 0.65% 53
2021
Q1 		$5.17M Buy
11,338
+1,928
+20% +$920K 0.58% 53
2020
Q4 		$4.38M Sell
9,410
-50
-0.5% -$23.4K 0.52% 52
2020
Q3 		$4.18M Buy
9,460
+59
+0.6% +$24.4K 0.55% 49
2020
Q2 		$3.41M Sell
9,401
-252
-3% -$84.5K 0.49% 52
2020
Q1 		$2.74M Sell
9,653
-125
-1% -$39.4K 0.48% 57
2019
Q4 		$3.18M Sell
9,778
-257
-3% -$77.9K 0.45% 60
2019
Q3 		$2.92M Sell
10,035
-85
-0.8% -$24.3K 0.45% 63
2019
Q2 		$2.97M Buy
10,120
+495
+5% +$136K 0.46% 61
2019
Q1 		$2.63M Sell
9,625
-430
-4% -$107K 0.42% 63
2018
Q4 		$2.25M Sell
10,055
-1,068
-10% -$251K 0.41% 65
2018
Q3 		$2.71M Buy
11,123
+250
+2% +$57.5K 0.42% 64
2018
Q2 		$2.25M Buy
10,873
+253
+2% +$53.7K 0.39% 68
2018
Q1 		$2.19M Sell
10,620
-1,698
-14% -$356K 0.39% 67
2017
Q4 		$2.34M Sell
12,318
-50
-0.4% -$9.58K 0.39% 70
2017
Q3 		$2.34M Buy
12,368
+8,529
+222% +$1.54M 0.42% 68
2017
Q2 		$670K Sell
3,839
-150
-4% -$25.2K 0.14% 100
2017
Q1 		$613K Sell
3,989
-350
-8% -$53.5K 0.13% 105
2016
Q4 		$612K Sell
4,339
-200
-4% -$29.5K 0.14% 109
2016
Q3 		$722K Hold
4,539
– – 0.16% 97
2016
Q2 		$671K Hold
4,539
– – 0.15% 104
2016
Q1 		$643K Sell
4,539
-350
-7% -$46.9K 0.15% 104
2015
Q4 		$694K Buy
4,889
+950
+24% +$127K 0.15% 96
2015
Q3 		$482K Buy
3,939
+1,000
+34% +$130K 0.11% 117
2015
Q2 		$381K Hold
2,939
– – 0.08% 131
2015
Q1 		$395K Sell
2,939
-100
-3% -$12.9K 0.09% 129
2014
Q4 		$381K Sell
3,039
-1,110
-27% -$135K 0.09% 129
2014
Q3 		$505K Sell
4,149
-205
-5% -$24.9K 0.12% 117
2014
Q2 		$514K Buy
4,354
+2,000
+85% +$235K 0.12% 119
2014
Q1 		$283K Hold
2,354
– – 0.07% 138
2013
Q4 		$262K Buy
+2,354
New +$234K 0.07% 125

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Middleton & Co's TMO Position: Q1 2026 in Review

Middleton & Co held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 5,137 shares worth $2.52M. The position accounts for 0.29% of the portfolio, ranked #66.

Middleton & Co first reported a position in TMO in Q4 2013 and has held it in 50 quarters since. The position peaked at $7.78M in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Middleton & Co held 5,137 shares of Thermo Fisher Scientific worth $2.52M as of Q1 2026.
  • Middleton & Co left its Thermo Fisher Scientific share count unchanged in Q1 2026.
  • Thermo Fisher Scientific made up 0.29% of Middleton & Co's portfolio in Q1 2026, its #66 holding.
  • Middleton & Co first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 50 quarters since.
  • Middleton & Co's Thermo Fisher Scientific position peaked at $7.78M in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Middleton & Co's 13F filing for Q1 2026, filed 8 May 2026.